TMC Life Sciences Bhd (0101) - Net Assets

Latest as of November 2025: RM860.77 Million MYR ≈ $216.11 Million USD

Based on the latest financial reports, TMC Life Sciences Bhd (0101) has net assets worth RM860.77 Million MYR (≈ $216.11 Million USD) as of November 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (RM1.12 Billion ≈ $280.98 Million USD) and total liabilities (RM258.38 Million ≈ $64.87 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 0101 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	RM860.77 Million
% of Total Assets	76.91%
Annual Growth Rate	16.23%
5-Year Change	8.03%
10-Year Change	34.49%
Growth Volatility	41.86

TMC Life Sciences Bhd - Net Assets Trend (2006–2025)

This chart illustrates how TMC Life Sciences Bhd's net assets have evolved over time, based on quarterly financial data. Also explore balance sheet size of TMC Life Sciences Bhd for the complete picture of this company's asset base.

Annual Net Assets for TMC Life Sciences Bhd (2006–2025)

The table below shows the annual net assets of TMC Life Sciences Bhd from 2006 to 2025. For live valuation and market cap data, see TMC Life Sciences Bhd stock valuation.

Year	Net Assets	Change
2025-08-31	RM853.04 Million ≈ $214.17 Million	-3.94%
2024-08-31	RM888.03 Million ≈ $222.96 Million	+3.03%
2023-08-31	RM861.96 Million ≈ $216.41 Million	+4.18%
2022-08-31	RM827.39 Million ≈ $207.73 Million	+4.78%
2021-08-31	RM789.62 Million ≈ $198.25 Million	+2.27%
2020-08-31	RM772.12 Million ≈ $193.85 Million	+1.30%
2019-08-31	RM762.24 Million ≈ $191.37 Million	+2.97%
2018-08-31	RM740.24 Million ≈ $185.85 Million	+3.61%
2017-08-31	RM714.42 Million ≈ $179.37 Million	+12.64%
2016-08-31	RM634.26 Million ≈ $159.24 Million	+110.22%
2015-08-31	RM301.71 Million ≈ $75.75 Million	+122.84%
2014-08-31	RM135.39 Million ≈ $33.99 Million	+3.11%
2013-08-31	RM131.31 Million ≈ $32.97 Million	+9.25%
2012-08-31	RM120.19 Million ≈ $30.18 Million	+81.99%
2011-08-31	RM66.04 Million ≈ $16.58 Million	-36.21%
2009-08-31	RM103.54 Million ≈ $25.99 Million	-9.19%
2008-08-31	RM114.02 Million ≈ $28.63 Million	+51.35%
2007-08-31	RM75.33 Million ≈ $18.91 Million	+53.85%
2006-08-31	RM48.97 Million ≈ $12.29 Million	--

Equity Component Analysis

This analysis shows how different components contribute to TMC Life Sciences Bhd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 941.2% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (August 2025)

Component	Amount	Percentage
Retained Earnings	RM227.06 Million	26.62%
Common Stock	RM625.99 Million	73.38%
Total Equity	RM853.04 Million	100.00%

TMC Life Sciences Bhd Competitors by Market Cap

The table below lists competitors of TMC Life Sciences Bhd ranked by their market capitalization.

Company	Market Cap
Cheil Electric Wiring Devices Co. Ltd. KQ:199820	$207.80 Million
TBS Energi Utama Tbk PT JK:TOBA	$207.85 Million
Iron Force Industrial Co Ltd TW:2228	$207.87 Million
Hanyang Sec KO:001750	$207.89 Million
Bank Nationalnobu Tbk JK:NOBU	$207.71 Million
Shanghai Jinqiao Export Processing Zone Development Co Ltd B SHG:900911	$207.67 Million
Utah Medical Products Inc NASDAQ:UTMD	$207.66 Million
Kaltura Inc NASDAQ:KLTR	$207.52 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in TMC Life Sciences Bhd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 888,034,000 to 853,043,000, a change of -34,991,000 (-3.9%).
Net income of 3,606,000 contributed positively to equity growth.
Dividend payments of 38,616,000 reduced retained earnings.
Other comprehensive income decreased equity by 1,316,000.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	RM3.61 Million	+0.42%
Dividends Paid	RM38.62 Million	-4.53%
Other Comprehensive Income	RM-1.32 Million	-0.15%
Other Changes	RM1.33 Million	+0.16%
Total Change	RM-	-3.94%

Book Value vs Market Value Analysis

This analysis compares TMC Life Sciences Bhd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 0.97x
The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
The price-to-book ratio has decreased from 1.78x to 0.97x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2006-08-31	RM0.27	RM0.48	x
2007-08-31	RM0.40	RM0.48	x
2008-08-31	RM0.20	RM0.48	x
2009-08-31	RM0.16	RM0.48	x
2011-08-31	RM0.11	RM0.48	x
2012-08-31	RM0.14	RM0.48	x
2013-08-31	RM0.11	RM0.48	x
2014-08-31	RM0.11	RM0.48	x
2015-08-31	RM0.31	RM0.48	x
2016-08-31	RM0.34	RM0.48	x
2017-08-31	RM0.38	RM0.48	x
2018-08-31	RM0.41	RM0.48	x
2019-08-31	RM0.44	RM0.48	x
2020-08-31	RM0.44	RM0.48	x
2021-08-31	RM0.45	RM0.48	x
2022-08-31	RM0.47	RM0.48	x
2023-08-31	RM0.49	RM0.48	x
2024-08-31	RM0.51	RM0.48	x
2025-08-31	RM0.49	RM0.48	x

Capital Efficiency Dashboard

This dashboard shows how efficiently TMC Life Sciences Bhd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 0.42%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 1.04%
• Asset Turnover: 0.31x
• Equity Multiplier: 1.33x
Recent ROE (0.42%) is below the historical average (0.82%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2006	18.72%	36.81%	0.41x	1.24x	RM4.27 Million
2007	12.38%	29.85%	0.33x	1.25x	RM1.80 Million
2008	3.14%	9.21%	0.23x	1.49x	RM-7.83 Million
2009	-8.51%	-18.65%	0.27x	1.68x	RM-19.15 Million
2011	-53.02%	-43.44%	0.55x	2.21x	RM-41.62 Million
2012	-5.34%	-10.36%	0.40x	1.28x	RM-18.44 Million
2013	8.44%	15.34%	0.46x	1.19x	RM-2.05 Million
2014	4.77%	7.47%	0.53x	1.22x	RM-7.08 Million
2015	3.29%	9.62%	0.30x	1.13x	RM-20.25 Million
2016	2.35%	11.66%	0.18x	1.10x	RM-48.53 Million
2017	3.64%	17.16%	0.20x	1.08x	RM-45.41 Million
2018	3.75%	16.44%	0.21x	1.08x	RM-46.23 Million
2019	2.74%	10.73%	0.23x	1.11x	RM-55.30 Million
2020	2.06%	8.65%	0.19x	1.23x	RM-61.28 Million
2021	2.57%	10.08%	0.19x	1.34x	RM-58.71 Million
2022	5.00%	16.98%	0.22x	1.37x	RM-41.35 Million
2023	4.55%	12.60%	0.26x	1.37x	RM-46.94 Million
2024	4.58%	11.73%	0.29x	1.34x	RM-48.16 Million
2025	0.42%	1.04%	0.31x	1.33x	RM-81.70 Million

Industry Comparison

This section compares TMC Life Sciences Bhd's net assets metrics with peer companies in the Medical Care Facilities industry.

Industry Context

Industry: Medical Care Facilities
Average net assets among peers: $4,921,137,690
Average return on equity (ROE) among peers: 6.18%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
TMC Life Sciences Bhd (0101)	RM860.77 Million	18.72%	0.30x	$207.73 Million
Optimax Holdings Sdn Bhd (0222)	$16.34 Million	45.23%	1.46x	$71.61 Million
Cengild Medical Berhad (0243)	$111.30 Million	9.95%	0.19x	$47.05 Million
DC HEALTHCARE HOLDINGS BERHAD (0283)	$44.74 Million	-43.92%	1.41x	$27.52 Million
ALPHA (0303)	$28.36 Million	8.70%	1.64x	$311.01 Million
IHH Healthcare Bhd (5225)	$27.28 Billion	6.83%	0.67x	$19.92 Billion
KPJ Healthcare Bhd (5878)	$2.05 Billion	10.31%	1.92x	$3.50 Billion

About TMC Life Sciences Bhd

KLSE:0101 Malaysia Medical Care Facilities

Market Cap

$207.73 Million

RM827.39 Million MYR

Market Cap Rank

#16522 Global

#206 in Malaysia

Share Price

RM0.48

Change (1 day)

-3.06%

52-Week Range

RM0.40 - RM0.57

All Time High

RM0.96